Hyloris Pharmaceuticals Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	13.78	23.59	30.41	33.46	50.01
Short-Term Investments	0.49	0.56	0.5	10.47	0.53
Cash & Short-Term Investments	14.27	24.15	30.91	43.93	50.54
Cash Growth	-40.92%	-21.86%	-29.64%	-13.09%	17.60%
Accounts Receivable	5.15	4.86	3.57	4.13	2.32
Total Trade Receivables	5.15	4.86	3.57	4.13	2.32
Inventory	0.05	-	-	-	-
Other Current Assets	0.49	0.7	0.84	1.75	1.1
Total Current Assets	19.96	29.71	35.31	49.8	53.96
Net Property, Plant & Equipment	1.69	1.99	2.15	1.06	0.3
Other Intangible Assets	5.69	3.84	3.83	3.61	2.94
Long-Term Investments	3.54	3.75	4.8	4.95	4.53
Other Long-Term Assets	2.48	2.05	1.59	1.31	1.71
Total Assets	33.36	41.34	47.68	60.73	63.44
Accounts Payable	4.7	3.43	3.32	2.42	2.75
Accrued Expenses	0.08	0.41	-	-	-
Current Portion of Long-Term Debt	0.36	0.33	0.24	0.14	0.07
Current Portion of Leases	-	3	3.2	3.21	11.82
Other Current Liabilities	-	-	-	-	0.35
Total Current Liabilities	5.13	7.16	6.76	5.77	14.98
Long-Term Debt	1.25	1.49	1.51	0.75	0.11
Long-Term Leases	0.09	0.07	0.34	0.3	0.3
Other Long-Term Liabilities	0.42	0.47	-	-	-
Total Long-Term Liabilities	1.75	2.03	1.85	1.05	0.41
Total Liabilities	6.88	9.19	8.61	6.82	15.39
Common Stock	-	-	0.14	0.14	0.13
Additional Paid-in Capital	121.51	121.51	119.21	118.67	102.26
Accumulated Other Comprehensive Income	-2.38	-3.04	0.48	0.48	0.48
Retained Earnings	-92.8	-86.47	-80.76	-65.38	-54.81
Total Common Shareholders' Equity	26.33	32	39.07	53.91	48.06
Shareholders' Equity	26.48	32.14	39.07	53.91	48.06
Total Liabilities & Equity	33.36	41.34	47.68	60.73	63.44
Total Debt	1.7	4.88	5.3	4.4	12.29
Net Cash (Debt)	12.57	19.27	25.61	39.53	38.25
Net Cash Growth	-34.76%	-24.77%	-35.21%	3.34%	6.04%
Net Cash Per Share	0.45	0.69	0.92	1.45	1.48
Book Value	26.33	32	39.07	53.91	48.06
Book Value Per Share	0.94	1.14	1.40	1.98	1.86
Tangible Book Value	20.65	28.17	35.24	50.3	45.11
Tangible Book Value Per Share	0.74	1.01	1.26	1.85	1.75